Crisis Interventions for Pediatric Providers - Autism Version (CIPP-A) for Providers
This study is looking at two ways to help pediatric healthcare providers support autistic youth who may be at risk for suicide. One is called the Safety Planning Intervention (SPI), which is a proven method for managing suicidal thoughts. The other is the Crisis Interventions for Pediatric Providers - Autism version (CIPP-A), which was developed specifically for autistic youth with input from autistic people. This study wants to see how practical and useful CIPP-A is for providers, and if it helps them feel more confident in managing suicide risk. Researchers will compare CIPP-A to SPI. This study is for pediatric healthcare providers in the U.S. who work with autistic youth. The study aims to enroll 70 participants, but its current status is unclear.
- Study design
- This interventional study aims to enroll 70 pediatric healthcare providers. Researchers will compare CIPP-A to the general Safety Planning Intervention (SPI).
- What's involved
- Participants will undergo remote training in either SPI or CIPP-A. The study measures how often providers use these interventions and their confidence in using them over 6 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants' use of interventions and confidence are measured from baseline to 6 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Crisis Interventions for Pediatric Providers - Autism Version
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Jessica Schwartzman, PhD · PRINCIPAL_INVESTIGATOR · Children's Hospital Los Angeles
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Feasibility: Number of times that providers use SPI or CIPP-A in 6 monthsBaseline to 6 months
The feasibility of SPI and CIPP-A will be assessed by an online survey of the number of times that providers used SPI/CIPP-A with autistic patients in 6 months. Higher scores indicate greater feasibility and use of SPI/CIPP-A (i.e., better outcome).The survey will be administered three times from baseline to 6 months.
- Acceptability: Acceptability of Intervention MeasureBaseline to 6 months
The Acceptability of Intervention Measure (AIM) will be administered to providers to assess perceived acceptability of SPI and CIPP-A. The AIM is a widely used measure of the extent to which stakeholders believe an intervention is satisfactory in a given setting (e.g., "I like SPI"). The AIM items are scored on a 5-point scale (1, completely disagree to 5, completely agree), with total scores ranging from 5-25. Higher scores indicate greater acceptability (i.e., better outcome). The AIM will be administered three times from baseline to 6 months.
- Initial Effectiveness: Providers confidence in using SPI or CIPP-ABaseline to 6 months
A series of visual analog scales (VAS; 0-100%) will be used to measure changes in providers' confidence in managing patient crises over the study, with total scores ranging from 0-100. Higher scores indicate greater effectiveness (i.e., better outcome). The VAS will be administered three times from baseline to 6 months.